National Guideline Clearinghouse | Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.

full-text ►

National Guideline Clearinghouse | Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.



National Institute for Health and Care Excellence (NICE)

Guideline Title

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Dec. 49 p. (Technology appraisal guidance; no. 327).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.